Dengue Virus and Chikungunya Virus Viral Load Quantitative Test in UAE | 600 AED | DHA Licensed

Executive Summary & Core Metrics

This quantitative PCR test delivers 99.9% diagnostic sensitivity for early detection and viral load monitoring of Dengue and Chikungunya infections, processed in an ISO 9001:2015‑certified laboratory. Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety. Results are available within 24–36 hours via secure channels, and post‑test clinical guidance is provided by a DHA‑licensed general practitioner. All practices are fully compliant with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.

✓ Accuracy: 99.9% sensitivity via Real‑Time PCR + WGS

✓ Logistics: Hospital Extraction Only (No home collection)

✓ Guidance: Free telephonic interpretation by DHA‑licensed GP

Test Overview & Methodology

The Dengue Virus and Chikungunya Virus Viral Load Quantitative Test uses advanced Real‑Time PCR (qPCR) and Whole Genome Sequencing (WGS) to accurately measure viral RNA copies in blood, serum, plasma, or cerebrospinal fluid. It provides definitive early diagnosis and viral kinetics for arboviral infections, helping physicians tailor treatment and monitor recovery. The assay targets conserved regions of the viral genomes with high specificity, minimising cross‑reactivity and window‑period false negatives.

Feature	Our Advanced PCR Test	Standard Serology / Rapid Test
Methodology	Real‑Time PCR + Whole Genome Sequencing	Immunoassay / Antigen detection
Diagnostic Sensitivity	99.9%	~70–85% (window period false negatives)
Turnaround Time	24h (critical) / 36h (routine)	2–5 days (standard lab)
Sample Type	Whole Blood, Serum, Plasma, CSF	Serum/plasma (limited)
UAE Compliance	ISO 9001:2015, DHA, PDPL, Federal Law 2/2019	Variable

Physician Insight & Safety Protocols

Dr. Ajay Singh (DHA: 36234132): “I understand the anxiety accompanying suspected arboviral infections—every hour matters. Quantitative viral load testing empowers us with precise data to distinguish active infection from past exposure, but it must always be interpreted alongside clinical symptoms and history. Remember, a low viral load does not exclude recent infection, and all treatment decisions require a comprehensive clinical evaluation. With hospital‑based sample collection, we ensure the highest safety standards for every patient.”

⚠️ Critical Safety Advisory

Important Safety Information

Do not discontinue any prescribed medication without consulting your physician, even if test results appear unremarkable.
Exclusion criteria: Inability to provide informed consent (mandatory per Federal Decree‑Law No. 4 of 2016 on Medical Liability), active hemorrhagic shock, severe thrombocytopenia with bleeding risk, or critically ill patients requiring emergency care.
Red‑flag symptoms — seek ER immediately: severe abdominal pain, persistent vomiting, bleeding gums or nosebleeds, difficulty breathing, or extreme lethargy.
Data privacy: All records are handled under Federal Decree‑Law No. 45 of 2021 (PDPL) and Federal Law No. 2 of 2019. No data is shared without explicit consent.

Patient Exclusion Criteria

Active hemorrhagic shock or severe thrombocytopenia.
Inability to provide informed consent (as per Federal Decree‑Law No. 4 of 2016).
Critically ill patients requiring immediate emergency intervention.
Patients with known contraindications to venipuncture in the hospital setting.

Patient FAQ & Clinical Guidance

1. What exactly does the Dengue and Chikungunya Viral Load Quantitative Test measure?

A: This test precisely quantifies the number of Dengue and Chikungunya virus RNA copies per millilitre of blood using Real‑Time PCR and Whole Genome Sequencing, providing early infection confirmation and monitoring viral clearance.

2. How is the sample collected, and why is it hospital‑only?

A: Since the test can require cerebrospinal fluid (CSF) or blood drawn under strict clinical conditions, sample collection is performed exclusively within a DHA‑licensed hospital facility. This ensures maximum safety, sterile technique, and immediate handling of any adverse events. Mobile phlebotomy is not available for this test.

3. When will I receive my results, and who interprets them?

A: Results are dispatched via secure email within 36 hours (critical values phoned within 24 hours). A DHA‑licensed general practitioner will provide complimentary telephonic guidance to help you understand the clinical significance of your viral load data.

UAE Regulatory & Data Privacy Adherence

All diagnostic procedures and data handling at DNA Labs UAE adhere strictly to the following UAE federal laws and regulations:

Federal Decree‑Law No. 45 of 2021 on the Protection of Personal Data (PDPL) – ensuring your health data is processed, stored, and shared only with your explicit consent and under strict security measures.
Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – governing the secure electronic handling of medical records.
Federal Decree‑Law No. 4 of 2016 on Medical Liability – establishing the legal framework for patient consent, safety protocols, and clinical accountability.
DHA regulations and ISO 9001:2015 quality management standards are applied throughout the laboratory workflow.

Clinical & Logistical Metadata

Test Name	Dengue Virus and Chikungunya Virus Viral Load Quantitative Test
Price (AED)	600
Turnaround Time	24–36 hours
Sample Type / Matrix	Whole Blood, Serum, Plasma, Cerebrospinal Fluid (CSF)
Methodology Used	Real‑Time PCR (qPCR) + Whole Genome Sequencing
ICD-10-CM Code	A90, A92.0
LOINC Code	29677-8
DHA Facility License & Address	License No. 1143 — Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE